Scientists in China have genetically modified human embryos in a
world first that has re-ignited the debate over the ethics and safety of
genetic therapies that have the potential to prevent inherited
diseases.
The work raises fresh questions over whether restrictions should be placed on a new wave of genetic techniques that are rapidly gaining ground in labs across the world.
The Chinese group used a genome editing procedure called Crispr to modify an aberrant gene that causes beta-thalassaemia, a life-threatening blood disorder, in faulty IVF embryos obtained from local fertility clinics.
The embryos used for their experiments were abnormal and incapable of developing into healthy babies and would have been destroyed by the clinics. They were not implanted into women once the modifications were made. READ MORE
The work raises fresh questions over whether restrictions should be placed on a new wave of genetic techniques that are rapidly gaining ground in labs across the world.
The Chinese group used a genome editing procedure called Crispr to modify an aberrant gene that causes beta-thalassaemia, a life-threatening blood disorder, in faulty IVF embryos obtained from local fertility clinics.
The embryos used for their experiments were abnormal and incapable of developing into healthy babies and would have been destroyed by the clinics. They were not implanted into women once the modifications were made. READ MORE
No comments:
Post a Comment